Specialty pharmaceuticals
S. 3187 Food and Drug Administration Safety and Innovation Act - Modification to REMS (risk evaluation and mitigation strategies) language;
H.R. 5651 Food and Drug Administration Reform Act of 2012 - Modification to REMS (risk evaluation and mitigation strategies) language S. 3187 Food and Drug Administration Safety and Innovation Act - Modification to REMS (risk evaluation and mitigation strategies) language;
H.R. 5651 Food and Drug Administration Reform Act of 2012 - Modification to REMS (risk evaluation and mitigation strategies) language
PHA - Pharmacy HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
AVENUE SOLUTIONS
401 9th St. NW, Suite 720, Washington, DC, 20004, US
ELIZABETH MACDONALD BARNETT TRACY SPICER AMY TEJRAL ELIZABETH MACDONALD BARNETT TRACY SPICER AMY TEJRAL